HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Wu Selected Research

1- (2- amino- 3- methyl- butyryl)- azetidine- 2- carbonitrile

6/2005DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Wu Research Topics

Disease

229Neoplasms (Cancer)
07/2024 - 03/2000
109Infections
03/2024 - 03/2005
51Breast Neoplasms (Breast Cancer)
02/2024 - 06/2011
41Inflammation (Inflammations)
03/2024 - 05/2006
36Plague (Bubonic Plague)
01/2024 - 01/2016
32Virus Diseases (Viral Diseases)
05/2024 - 05/2008
32Neoplasm Metastasis (Metastasis)
12/2023 - 10/2011
28Hepatocellular Carcinoma (Hepatoma)
06/2023 - 02/2007
23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 07/2011
21Obesity
03/2024 - 04/2002
21Hypoxia (Hypoxemia)
11/2023 - 06/2006
20Fibrosis (Cirrhosis)
05/2024 - 11/2007
20Parkinson Disease (Parkinson's Disease)
03/2024 - 01/2015
18Type 2 Diabetes Mellitus (MODY)
06/2023 - 10/2008
17Lung Neoplasms (Lung Cancer)
03/2024 - 12/2012
17Carcinogenesis
12/2023 - 02/2013
17Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2010
16Insulin Resistance
03/2024 - 01/2012
16Hypertension (High Blood Pressure)
12/2023 - 04/2011
16Enteritis
01/2021 - 12/2010
15Melanoma (Melanoma, Malignant)
12/2023 - 01/2018
14Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 01/2002
14Carcinoma (Carcinomatosis)
12/2022 - 09/2003
13Disease Progression
12/2023 - 01/2012
12Adenocarcinoma of Lung
03/2024 - 04/2015
12Triple Negative Breast Neoplasms
02/2024 - 03/2016
12Neuralgia (Stump Neuralgia)
01/2021 - 06/2012
11COVID-19
01/2023 - 05/2020
11Pain (Aches)
01/2022 - 02/2004
11Colonic Neoplasms (Colon Cancer)
04/2015 - 01/2008
10Glioma (Gliomas)
03/2024 - 11/2002
10Seizures (Absence Seizure)
01/2023 - 01/2006
9Body Weight (Weight, Body)
07/2024 - 05/2005
9Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 12/2011
9Adenocarcinoma
12/2023 - 06/2010
9Atrial Fibrillation
01/2023 - 01/2014
9HIV Infections (HIV Infection)
11/2014 - 08/2003
8Lymphatic Metastasis
04/2024 - 06/2013
8Wounds and Injuries (Trauma)
02/2024 - 12/2012
8Leukemia
12/2023 - 06/2011
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 02/2015
8Liver Cirrhosis (Hepatic Cirrhosis)
09/2023 - 02/2018
8Diabetes Mellitus
07/2023 - 07/2012
8Rheumatoid Arthritis
01/2023 - 08/2009
8Bites and Stings (Sting)
03/2022 - 01/2018
8Hyperalgesia
12/2018 - 02/2004
7Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 01/2015
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 10/2011
7Delirium
01/2024 - 01/2016

Drug/Important Bio-Agent (IBA)

128Proteins (Proteins, Gene)FDA Link
05/2024 - 12/2003
74Biomarkers (Surrogate Marker)IBA
03/2024 - 04/2007
41MicroRNAs (MicroRNA)IBA
01/2024 - 03/2010
32Long Noncoding RNAIBA
12/2023 - 04/2015
29Glucose (Dextrose)FDA LinkGeneric
03/2024 - 10/2008
28VaccinesIBA
03/2024 - 06/2007
28Antiviral Agents (Antivirals)IBA
01/2024 - 12/2010
24Messenger RNA (mRNA)IBA
12/2022 - 03/2005
23RNA (Ribonucleic Acid)IBA
01/2024 - 01/2006
23CytokinesIBA
12/2023 - 03/2010
20LipidsIBA
04/2024 - 06/2007
20DNA (Deoxyribonucleic Acid)IBA
05/2023 - 07/2004
17Interleukin-6 (Interleukin 6)IBA
05/2024 - 03/2013
17Phosphotransferases (Kinase)IBA
02/2024 - 12/2013
16Peptides (Polypeptides)IBA
02/2024 - 10/2011
15InterferonsIBA
11/2023 - 06/2002
14EnzymesIBA
11/2023 - 01/2009
14Therapeutic UsesIBA
09/2023 - 01/2005
13Indicators and Reagents (Reagents)IBA
07/2023 - 06/2011
13Small Interfering RNA (siRNA)IBA
01/2022 - 03/2005
12ErbB Receptors (EGF Receptor)IBA
03/2024 - 01/2013
11Doxorubicin (Adriamycin)FDA LinkGeneric
07/2024 - 02/2012
11CateninsIBA
04/2023 - 01/2006
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2004
11Estrogen ReceptorsIBA
10/2022 - 06/2016
10Triglycerides (Triacylglycerol)IBA
04/2024 - 07/2009
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2023 - 05/2005
10Transcription Factors (Transcription Factor)IBA
02/2023 - 12/2010
10Insulin (Novolin)FDA Link
01/2018 - 04/2009
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 10/2014
9Immune Checkpoint InhibitorsIBA
07/2023 - 01/2019
8Caspase 3 (Caspase-3)IBA
02/2024 - 06/2007
8CalciumIBA
01/2024 - 12/2007
8Tyrosine Kinase InhibitorsIBA
01/2024 - 01/2013
8Viral ProteinsIBA
01/2024 - 01/2020
8NucleotidesIBA
12/2023 - 10/2008
8ProdrugsIBA
11/2023 - 01/2017
8CollagenIBA
09/2023 - 01/2019
8Glycoproteins (Glycoprotein)IBA
05/2023 - 05/2011
8human ERBB2 proteinIBA
10/2022 - 04/2017
8AntibodiesIBA
05/2022 - 12/2003
7CholesterolIBA
04/2024 - 11/2013
7butyl phosphorotrithioate (DEF)IBA
01/2024 - 04/2018

Therapy/Procedure

111Therapeutics
04/2024 - 03/2000
53Drug Therapy (Chemotherapy)
07/2024 - 05/2004
17Immunotherapy
04/2024 - 09/2017
17Radiotherapy
03/2024 - 11/2018
11Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 02/2012
9Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2024 - 10/2017
8Lasers (Laser)
01/2023 - 06/2007
7Aftercare (After-Treatment)
04/2024 - 04/2012